series-c-plus
Stage
1
Investors
About
Ecrins Therapeutics is a French biotechnology company developing innovative anti-cancer drugs. Their approach targets tumor metabolism with a new mechanism of action.
Explore Ecrins Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.